查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
心臟生物標記市場規模 - 按產品（肌鈣蛋白、CK-MB、肌紅蛋白、利鈉肽、CRP、缺血修飾白蛋白）、應用、最終用途 - 全球預測，2023-2032 年
市場調查報告書
商品編碼
1392199

心臟生物標記市場規模 - 按產品（肌鈣蛋白、CK-MB、肌紅蛋白、利鈉肽、CRP、缺血修飾白蛋白）、應用、最終用途 - 全球預測，2023-2032 年

Cardiac Biomarkers Market Size - By Product (Troponins, CK-MB, Myoglobin, Natriuretic Peptides, CRP, Ischemia Modified Albumin), Application, End-use - Global Forecast, 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

2023年至2032年，心臟生物標記市場規模預計將達到12.8%的CAGR。全球心血管疾病盛行率不斷上升，加上人口老化，刺激了對先進診斷工具的需求。根據世界心臟聯盟（WHF）的最新報告，2021年有近2,050萬人死於心血管疾病（CVD）。

尖端技術的出現和對早期檢測的日益重視提高了心臟生物標記在臨床實踐中的重要性。這些生物標記，從蛋白質到遺傳標記物，正在成為醫療保健專業人員預測、診斷和管理心血管疾病不可或缺的工具，從而重塑心臟護理的模式。

心臟生物標記市場根據產品、應用、最終用途和地區進行分類。

預計到2032 年，利鈉肽領域將產生大量收入。利鈉肽，特別是B 型利鈉肽(BNP) 和N 末端B 型利鈉肽原(NT-proBNP)，已成為心臟衰竭的關鍵指標。這些胜肽在檢測心臟壓力和功能障礙方面的精確度和敏感性引起了醫療保健提供者的廣泛關注。隨著技術的進步，新型利尿鈉肽檢測方法的開發有望提高診斷準確性，為臨床醫生提供強大的早期介入和個人化治療策略。

受全球心臟衰竭流行的推動，到 2032 年，充血性心臟衰竭 (CHF) 應用領域將對心臟生物標記產生大量需求。隨著 CHF 病例數量的驚人增加，CHF 生物標記譜，包括肌鈣蛋白、肌酸激酶-MB (CK-MB) 和肌紅蛋白，有助於心臟功能的全面評估。將這些生物標記整合到常規臨床實踐中正在重塑心臟衰竭的治療方法，以實現及時干預並改善患者預後。

歐洲心臟生物標記產業預計在 2023 年至 2032 年期間將錄得強勁的CAGR，這得益於心血管護理範式轉變，並且越來越重視預防措施和個人化醫療。在醫療機構和創新診斷公司之間的合作推動下，產品融入常規臨床實踐的勢頭正在增強。隨著歐洲地區繼續擁抱最新進展，市場預計將持續成長，開創整個歐洲大陸心血管保健的新時代。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：心臟生物標記產業見解

  • COVID-19 影響分析
  • 產業生態系統分析
  • 技術景觀
  • 監管環境
  • 產業影響力
    • 成長動力
      • 心血管疾病盛行率增加
      • 老年人口的增加導致心臟相關疾病的盛行率更高
      • 不斷增加的臨床研究旨在發現新的心臟生物標記
      • 增加即時檢測
    • 產業陷阱與挑戰
      • 嚴格的監管框架
      • 心臟影像技術的存在與進步
  • 成長潛力分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
    • Abbott Diagnostics
    • Roche Diagnostics
    • Siemens Healthineers
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：心臟生物標記市場規模與預測：按產品分類，2018-2032 年

  • 主要動向：按產品
  • 肌鈣蛋白
  • 肌酸激酶-MB (CK-MB)
  • 肌紅蛋白
  • 利鈉肽
  • C反應蛋白（CRP）
  • 缺血修飾白蛋白
  • 其他產品

第 6 章：心臟生物標記市場規模和預測：按應用，2018-2032

  • 主要動向：按應用
  • 充血性心臟衰竭
  • 心肌梗塞
  • 急性冠狀動脈綜合症
  • 動脈粥狀硬化
  • 其他應用

第 7 章：心臟生物標記市場規模與預測：依最終用途，2018-2032 年

  • 主要動向：依最終用途
  • 醫院實驗室
  • 照護端測試設施
  • 診斷設施
  • 其他最終用戶

第 8 章：心臟生物標記市場規模與預測：按地區分類，2018-2032 年

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Abbott Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Ortho Clinical Diagnostics
  • Randox Laboratories
  • Quidel Corporation
  • Radiometer
  • Tosoh Corporation
  • Meso Scale Diagnostics (MSD)
  • Thermo Fisher Scientific
  • Luminex Corporation
  • Trinity Biotech
  • Biomerieux
Product Code: 7121

Cardiac biomarkers market size is expected to record 12.8% CAGR from 2023 to 2032. The rising prevalence of cardiovascular diseases worldwide, coupled with an aging population, has spurred the need for advanced diagnostic tools. According to a new report from the World Heart Federation (WHF), nearly 20.5 million deaths happened due to cardiovascular (CVD) in 2021.

The advent of cutting-edge technologies and the growing emphasis on early detection have elevated the importance of cardiac biomarkers in clinical practice. These biomarkers, ranging from proteins to genetic markers, are becoming indispensable tools for healthcare professionals in predicting, diagnosing, and managing cardiovascular conditions, thus reshaping the landscape of cardiac care.

The cardiac biomarkers market is classified based on product, application, end-use, and region.

The natriuretic peptides segment is predicted to generate massive revenues by 2032. Natriuretic peptides, particularly B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), have become pivotal indicators for heart failure. The precision and sensitivity of these peptides in detecting cardiac stress and dysfunction have garnered widespread attention from healthcare providers. As technology advances, the development of novel natriuretic peptide assays promises enhanced diagnostic accuracy, providing clinicians with a powerful arsenal for early intervention and personalized treatment strategies.

The Congestive Heart Failure (CHF) application segment will generate high demand for cardiac biomarkers through 2032, driven by the global epidemic of heart failure. With a staggering rise in the number of CHF cases, the spectrum of CHF biomarkers, including troponins, creatine kinase-MB (CK-MB), and myoglobin, aid in the comprehensive evaluation of cardiac function. The integration of these biomarkers into routine clinical practice is reshaping the approach of managing heart failure, enabling timely interventions and improving patient outcomes.

Europe cardiac biomarkers industry is anticipated to record strong CAGR from 2023 to 2032, favored by a paradigm shift in cardiovascular care, with an increasing emphasis on preventive measures and personalized medicine. The product integration into routine clinical practice is gaining momentum, driven by collaborative efforts between healthcare institutions and innovative diagnostic companies. As the Europe region continues to embrace the latest advancements, the market is poised for sustained growth, ushering in a new era of cardiovascular healthcare across the continent.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
  • 1.3 Forecast calculations
  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global cardiac biomarkers market 360 degree synopsis, 2018 - 2032
  • 2.2 Regional trends
  • 2.3 Product trends
  • 2.4 Application trends
  • 2.5 End-use trends

Chapter 3 Cardiac Biomarkers Industry Insights

  • 3.1 COVID- 19 impact analysis
  • 3.2 Industry ecosystem analysis
  • 3.3 Technology landscape
  • 3.4 Regulatory landscape
  • 3.5 Industry impact forces
    • 3.5.1 Growth drivers
      • 3.5.1.1 Increase in prevalence of cardiovascular diseases
      • 3.5.1.2 Rise in the elderly population is leading to a higher prevalence of heart-related conditions
      • 3.5.1.3 Rising clinical research studies aimed at discovering new cardiac biomarkers
      • 3.5.1.4 Increase in point-of-care testing
    • 3.5.2 Industry pitfalls & challenges
      • 3.5.2.1 Stringent regulatory frameworks
      • 3.5.2.2 Presence and advancement in cardiac imaging technologies
  • 3.6 Growth potential analysis
    • 3.6.1 By product
    • 3.6.2 By application
    • 3.6.3 By end-use
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
    • 4.1.1 Abbott Diagnostics
    • 4.1.2 Roche Diagnostics
    • 4.1.3 Siemens Healthineers
  • 4.2 Competitive analysis of major market players, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic outlook matrix, 2022

Chapter 5 Cardiac Biomarkers Market Size and Forecast, By Product, 2018-2032 (USD Million)

  • 5.1 Key trends, by product
  • 5.2 Troponins
  • 5.3 Creatine kinase-MB (CK-MB)
  • 5.4 Myoglobin
  • 5.5 Natriuretic peptides
  • 5.6 C-reactive protein (CRP)
  • 5.7 Ischemia modified albumin
  • 5.8 Other products

Chapter 6 Cardiac Biomarkers Market Size and Forecast, By Application, 2018-2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Congestive heart failure
  • 6.3 Myocardial infarction
  • 6.4 Acute coronary syndrome
  • 6.5 Atherosclerosis
  • 6.6 Other applications

Chapter 7 Cardiac Biomarkers Market Size and Forecast, By End-use, 2018-2032 (USD Million)

  • 7.1 Key trends, by end-use
  • 7.2 Hospital laboratory
  • 7.3 Point of care testing facilities
  • 7.4 Diagnostic facilities
  • 7.5 Other end-users

Chapter 8 Cardiac Biomarkers Market Size and Forecast, By Region, 2018-2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Diagnostics
  • 9.2 Roche Diagnostics
  • 9.3 Siemens Healthineers
  • 9.4 Beckman Coulter
  • 9.5 Bio-Rad Laboratories
  • 9.6 Ortho Clinical Diagnostics
  • 9.7 Randox Laboratories
  • 9.8 Quidel Corporation
  • 9.9 Radiometer
  • 9.10 Tosoh Corporation
  • 9.11 Meso Scale Diagnostics (MSD)
  • 9.12 Thermo Fisher Scientific
  • 9.13 Luminex Corporation
  • 9.14 Trinity Biotech
  • 9.15 Biomerieux

Data Tables

  • TABLE 1 Industry impact forces
  • TABLE 2 Competitive analysis of major market players
  • TABLE 3 Competitive positioning matrix: Classification criteria
  • TABLE 4 Troponins market size, 2018 - 2024 (USD Million)
  • TABLE 5 Troponins market size, 2025 - 2032 (USD Million)
  • TABLE 6 CK-MB market size, 2018 - 2024 (USD Million)
  • TABLE 7 CK-MB market size, 2025 - 2032 (USD Million)
  • TABLE 8 Myoglobin market size, 2018 - 2024 (USD Million)
  • TABLE 9 Myoglobin market size, 2025 - 2032 (USD Million)
  • TABLE 10 Natriuretic peptides market size, 2018 - 2024 (USD Million)
  • TABLE 11 Natriuretic peptides market size, 2025 - 2032 (USD Million)
  • TABLE 12 CRP market size, 2018 - 2024 (USD Million)
  • TABLE 13 CRP market size, 2025 - 2032 (USD Million)
  • TABLE 14 Ischemia modified albumin market size, 2018 - 2024 (USD Million)
  • TABLE 15 Ischemia modified albumin market size, 2025 - 2032 (USD Million)
  • TABLE 16 Other products market size, 2018 - 2024 (USD Million)
  • TABLE 17 Other products market size, 2025 - 2032 (USD Million)
  • TABLE 18 Congestive heart failure market size, 2018 - 2024 (USD Million)
  • TABLE 19 Congestive heart failure market size, 2025 - 2032 (USD Million)
  • TABLE 20 Myocardial infarction market size, 2018 - 2024 (USD Million)
  • TABLE 21 Myocardial infarction market size, 2025 - 2032 (USD Million)
  • TABLE 22 Acute coronary syndrome market size, 2018 - 2024 (USD Million)
  • TABLE 23 Acute coronary syndrome market size, 2025 - 2032 (USD Million)
  • TABLE 24 Atherosclerosis market size, 2018 - 2024 (USD Million)
  • TABLE 25 Atherosclerosis market size, 2025 - 2032 (USD Million)
  • TABLE 26 Other application market size, 2018 - 2024 (USD Million)
  • TABLE 27 Other application market size, 2025 - 2032 (USD Million)
  • TABLE 28 Hospital laboratory market size, 2018 - 2024 (USD Million)
  • TABLE 29 Hospital laboratory market size, 2025 - 2032 (USD Million)
  • TABLE 30 Point of care testing facilities market size, 2018 - 2024 (USD Million)
  • TABLE 31 Point of care testing facilities market size, 2025 - 2032 (USD Million)
  • TABLE 32 Diagnostic facilities market size, 2018 - 2024 (USD Million)
  • TABLE 33 Diagnostic facilities market size, 2025 - 2032 (USD Million)
  • TABLE 34 Other end-users market size, 2018 - 2024 (USD Million)
  • TABLE 35 Other end-users market size, 2025 - 2032 (USD Million)
  • TABLE 36 North America cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 37 North America cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 38 North America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 39 North America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 40 North America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 41 North America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 42 North America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 43 North America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 44 U.S. cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 45 U.S. cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 46 U.S. cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 47 U.S. cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 48 U.S. cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 49 U.S. cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 50 Canada cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 51 Canada cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 52 Canada cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 53 Canada cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 54 Canada cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 55 Canada cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 56 Europe cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 57 Europe cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 58 Europe cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 59 Europe cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 60 Europe cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 61 Europe cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 62 Europe cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 63 Europe cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 64 Germany cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 65 Germany cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 66 Germany cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 67 Germany cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 68 Germany cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 69 Germany cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 70 UK cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 71 UK cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 72 UK cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 73 UK cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 74 UK cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 75 UK cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 76 France cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 77 France cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 78 France cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 79 France cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 80 France cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 81 France cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 82 Italy cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 83 Italy cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 84 Italy cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 85 Italy cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 86 Italy cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 87 Italy cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 88 Spain cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 89 Spain cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 90 Spain cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 91 Spain cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 92 Spain cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 93 Spain cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 94 Rest of Europe cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 95 Rest of Europe cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 96 Rest of Europe cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 97 Rest of Europe cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 98 Rest of Europe cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 99 Rest of Europe cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 100 Asia Pacific cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 101 Asia Pacific cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 102 Asia Pacific cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 103 Asia Pacific cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 104 Asia Pacific cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 105 Asia Pacific cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 106 Asia Pacific cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 107 Asia Pacific cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 108 China cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 109 China cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 110 China cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 111 China cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 112 China cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 113 China cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 114 Japan cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 115 Japan cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 116 Japan cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 117 Japan cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 118 Japan cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 119 Japan cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 120 India cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 121 India cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 122 India cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 123 India cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 124 India cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 125 India cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 126 Australia cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 127 Australia cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 128 Australia cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 129 Australia cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 130 Australia cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 131 Australia cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 132 South Korea cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 133 South Korea cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 134 South Korea cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 135 South Korea cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 136 South Korea cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 137 South Korea cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 138 Rest of Asia Pacific cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 139 Rest of Asia Pacific cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 140 Rest of Asia Pacific cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 141 Rest of Asia Pacific cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 142 Rest of Asia Pacific cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 143 Rest of Asia Pacific cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 144 Latin America cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 145 Latin America cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 146 Latin America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 147 Latin America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 148 Latin America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 149 Latin America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 150 Latin America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 151 Latin America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 152 Brazil cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 153 Brazil cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 154 Brazil cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 155 Brazil cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 156 Brazil cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 157 Brazil cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 158 Mexico cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 159 Mexico cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 160 Mexico cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 161 Mexico cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 162 Mexico cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 163 Mexico cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 164 Argentina cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 165 Argentina cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 166 Argentina cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 167 Argentina cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 168 Argentina cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 169 Argentina cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 170 Rest of Latin America cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 171 Rest of Latin America cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 172 Rest of Latin America cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 173 Rest of Latin America cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 174 Rest of Latin America cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 175 Rest of Latin America cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 176 Middle East & Africa cardiac biomarkers market size, by country, 2018 - 2024 (USD Million)
  • TABLE 177 Middle East & Africa cardiac biomarkers market size, by country, 2025 - 2032 (USD Million)
  • TABLE 178 Middle East & Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 179 Middle East & Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 180 Middle East & Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 181 Middle East & Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 182 Middle East & Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 183 Middle East & Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 184 Saudi Arabia cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 185 Saudi Arabia cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 186 Saudi Arabia cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 187 Saudi Arabia cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 188 Saudi Arabia cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 189 Saudi Arabia cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 190 South Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 191 South Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 192 South Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 193 South Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 194 South Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 195 South Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 196 UAE cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 197 UAE cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 198 UAE cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 199 UAE cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 200 UAE cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 201 UAE cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)
  • TABLE 202 Rest of Middle East & Africa cardiac biomarkers market size, by product, 2018- 2024 (USD Million)
  • TABLE 203 Rest of Middle East & Africa cardiac biomarkers market size, by product, 2025- 2032 (USD Million)
  • TABLE 204 Rest of Middle East & Africa cardiac biomarkers market size, by application, 2018 - 2024 (USD Million)
  • TABLE 205 Rest of Middle East & Africa cardiac biomarkers market size, by application, 2025 - 2032 (USD Million)
  • TABLE 206 Rest of Middle East & Africa cardiac biomarkers market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 207 Rest of Middle East & Africa cardiac biomarkers market size, by end-use, 2025 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Research design
  • FIG. 2 Data collection techniques
  • FIG. 3 Primary research process
  • FIG. 4 Market sizing approach
  • FIG. 5 Forecasting model
  • FIG. 6 Global industry snapshot
  • FIG. 7 Industry ecosystem analysis
  • FIG. 8 Growth potential analysis, by product
  • FIG. 9 Growth potential analysis, by application
  • FIG. 10 Growth potential analysis, by end-use
  • FIG. 11 Porter's analysis
  • FIG. 12 PESTEL analysis
  • FIG. 13 Company market share analysis, 2022
  • FIG. 14 Competitive analysis of major market players, 2022
  • FIG. 15 Competitive positioning matrix, 2022
  • FIG. 16 Strategic outlook matrix, 2022